Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Over the past three decades, the treatment of malignant central nervous system (CNS) tumors has become increasingly challenging, with only a few therapeutic ...

CLEVELAND (WJW) — Jennifer Frederick never thought it would happen to her. She was 49 and active — until a strange lump ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic ...

Clinical trial advances for INSTASYL siRNA lead product candidate PH-762 4th Cohort enrolling and treating patients in ...

Research from The University of Western Australia has advanced the development of cancer treatments that enable immune cells ...

Ideaya Biosciences, Inc. progresses trials for uveal melanoma and solid tumors, with key upcoming data milestones. Click for ...

Summer can mean a rise in visible freckles. But how do you know when a freckle is harmless versus whether it might actually ...

The study, which used flow cytometry rather than molecular biology to identify circulating tumor cells (CTCs), found a ...

At the upcoming ASCO Annual Meeting, we will present another Phase 1b clinical update on our PRAME cell therapy, IMA203, in ...

Edward Duffield said he found out he had melanoma during a routine skin screening with his doctor. He hopes his experience serves as a reminder to other firefighters to not skip routine check-ups ...